A company recently sent the Arkansas Times a press release advertising its cannabidiol (CBD) products, claiming they help with "relief of chronic pain," "anti-inflammatory benefits," "anxiety relief," "sleep," and "Cancer, Parkinson's, and Diabetes fighting properties."
Making such claims is against FDA guidelines. The FDA is researching cannabidiol "as a new drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public." Therefore, you cannot sell CBD as a dietary supplement — it's a drug. The FDA recently wrote warnings to a group of CBD sellers about this.
But that doesn't mean CBD products can't be sold. They just can't be sold as dietary supplements or vitamins. It's about the advertising.
